PharmiWeb.com - Global Pharma News & Resources
01-Sep-2022

Zur Rose Group successfully completes placement of approx. CHF 95 million Convertible Bonds and the approx. CHF 44 million Capital Increase by way of an accelerated book building process

Zur Rose Group AG / Key word(s): Corporate Action

01-Sep-2022 / 07:00 CET/CEST
Release of an ad hoc announcement pursuant to Art. 53 LR
The issuer is solely responsible for the content of this announcement.


Please find our press release about a capital measure under the following link:
https://zurrosegroup.com/websites/zurrosegroup/English/204020/financing.html
 

End of Inside Information
Language: English
Company: Zur Rose Group AG
Walzm├╝hlestrasse 60
8500 Frauenfeld
Switzerland
Phone: +41 52 724 08 14
Internet: www.zurrosegroup.com
ISIN: CH0042615283
Listed: SIX Swiss Exchange
EQS News ID: 1432837

 
End of Announcement EQS News Service

Editor Details

Last Updated: 01-Sep-2022